These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23778116)

  • 1. Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods.
    Cengiz M; Sahinturk P
    J Antibiot (Tokyo); 2013 Oct; 66(10):629-31. PubMed ID: 23778116
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
    Noguera O; López-Riquelme N; Rodríguez JC; Belda S; Galiana A; Ruiz-García M; López-García P; Royo G
    J Antimicrob Chemother; 2011 Sep; 66(9):2182-4. PubMed ID: 21693462
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
    Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
    Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
    Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
    Sorlozano A; Gutierrez J; Jimenez A; de Dios Luna J; Martínez JL
    J Clin Microbiol; 2007 Aug; 45(8):2740-2. PubMed ID: 17567787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
    Ferran A; Dupouy V; Toutain PL; Bousquet-Mélou A
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4163-6. PubMed ID: 17709467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.
    Jones RN; Biedenbach DJ; Ambrose PG; Wikler MA
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):110-2. PubMed ID: 18620833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
    Pankey GA; Ashcraft DS
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated quinolone resistance genes in enteroaggregative Escherichia coli from infants in Lima, Peru.
    Riveros M; Riccobono E; Durand D; Mosquito S; Ruiz J; Rossolini GM; Ochoa TJ; Pallecchi L
    Int J Antimicrob Agents; 2012 Jun; 39(6):540-2. PubMed ID: 22521526
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants.
    Yang J; Luo Y; Li J; Ma Y; Hu C; Jin S; Ye L; Cui S
    J Antimicrob Chemother; 2010 Mar; 65(3):453-9. PubMed ID: 20056688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
    Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
    J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b.
    Hata M; Suzuki M; Matsumoto M; Takahashi M; Sato K; Ibe S; Sakae K
    Antimicrob Agents Chemother; 2005 Feb; 49(2):801-3. PubMed ID: 15673773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and characteristics of β-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China.
    Jiang HX; Tang D; Liu YH; Zhang XH; Zeng ZL; Xu L; Hawkey PM
    J Antimicrob Chemother; 2012 Oct; 67(10):2350-3. PubMed ID: 22809702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.